ADHD symptoms typically emerge in childhood, and Lisa had no history of attention difficulties when she was younger
Semaglutide Industry Developments June 2026 : Novo Nordisk presented Phase 3 results of its REIMAGINE 1-3 trials
Scientifically, PT-141 is a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone (-MSH), specifically targeting the melanocortin-4 receptor (MC4R) to enhance sexual signaling without affecting blood pressure or heart rate like some other treatments.[4] At the most basic level, PT-141 activates brain centers that control sexual desire, increasing blood flow to genital tissues, improving sensitivity, and promoting natural lubricationall without relying on hormonal changes, making it suitable for women who can't or prefer not to use estrogen-based therapies.[4] Its role goes far beyond just sparking interest
Compounded PT-141 used in functional medicine is the same molecule but not the FDA-approved formulation
Ellagic acid and intestinal microflora metabolite urolithin A: a review on its sources, metabolic distribution, health benefits, and biotransformation